Thermo and Waters Savor Growth from Acquisitions, and Are Ready for More Shopping | GenomeWeb

Thermo Electron and Waters, two of the leading life science instrument sellers, figuratively on Monday pulled out their wallets to tell Wall Street analysts they are in a mood to buy.

Presenting at the Bear Stearns Healthcare Conference in New York, Thermo announced plans to acquire InnaPhase, a Philadelphia-based supplier of data-management software and services, and Marijn Dekkers, president and CEO, said the company might consider spending a lot more.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.